Financial Summary (All financials)
| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 15.7 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 15.7 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | |
| Research and development | 83.8 | 56.7 | 37.2 | 14.5 |
| General and administrative | 20.4 | 15.4 | 8.1 | 5.2 |
| EBIT | -88.5 | -72.1 | -45.3 | -19.6 |
| EBIT margin | -564.7% | | | |
| Pre-tax income | -87.6 | -70.4 | -44.9 | -19.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -87.6 | -70.4 | -44.9 | -19.5 |
| Net margin | -558.9% | | | |
| |
| Diluted EPS | ($2.40) | ($3.75) | ($6.94) | ($3.15) |
| Shares outstanding (diluted) | 36.4 | 18.8 | 6.5 | 6.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|